Pharma & Healthcare
Multi-Country Investigator Meeting
A compliance-sensitive scientific meeting for clinical investigators across 18 countries, managed with documentation rigour, speaker precision, and duty-of-care protocols.
The situation
The program required full spend documentation for regulatory compliance, careful HCP travel management, and a scientific agenda that ran to the minute across three parallel tracks.
A global pharmaceutical company needed to bring 190 clinical trial investigators from 18 countries to a central investigator meeting. Regulatory requirements specified complete spend transparency for all healthcare professional (HCP) attendees, individual country-specific compliance review, and documentation of all communications from invitation to post-event close.
The scientific agenda ran three parallel breakout tracks, with plenary sessions requiring simultaneous interpretation into four languages. Travel logistics covered 38 different origin airports, visa support for attendees from 9 countries, and a duty-of-care protocol that covered medical support, dietary requirements, and mobility assistance for 12 attendees.
Solution
How Voya Circle structured the operating response.
Impact
Operational improvements created by the program model.
100% compliance documentation deliveredZero agenda overruns across 3 tracksPositive investigator experience scoresPost-event report delivered within 5 working days
Lesson 1
HCP compliance documentation must begin at invitation stage — retrofitting it after the program is error-prone and resource-intensive.
Lesson 2
Multi-track scientific agendas require a dedicated show-caller per track, not a single coordinator managing all three.
Lesson 3
Duty-of-care briefing documents for scientific meetings should go beyond emergency contacts to include medical, mobility, and dietary protocols for every named attendee.
Build similar work